✓Tender information last checkedLast checked 13 Oct 2026, 15:59.
Opportunity overview
The North East & Yorkshire NHS Pharmaceutical Purchasing Consortium (NEYPPC) intend to establish a Framework Agreement for the provision of High Tech Homecare Medicines Services. The scope of this procurement will encompass all High Tech Homecare Medicines Services required by member Trusts within the NEY region, while also allowing access for non-member Trusts. Access for non-member Trusts will be available to any publicly funded entity, subject to prior approval from the Authority. The expectation is that the Framework will be multi-award, structured into the following Lots:
Lot HT26-A: Unlicensed Compounded Desferrioxamine Homecare Medicines Services
Lot HT26-B: Unlicensed Compounded Antimicrobial Homecare Medicines Services
Lot HT26-C: Unlicensed Compounded Chemotherapy and Monoclonal Antibody Homecare Medicines Services
Lot HT26-D: Other Unlicensed Compounded Homecare Medicines Services
Lot HT26-E: Metabolic Disorders Homecare Medicines Services Medicines
Lot HT26-F: Other Non-compounded High Tech Homecare Medicines Services
Invitation to Tender Pack for NEYPPC High Tech Homecare Medicines ServicesOpen source ↗
Published notice details
Additional information from the published procurement release. Fields appear only when supplied by the source; check the original notice and tender documents before acting.
Scope, procedure and submissions
Id
C425492
Status
active
Procurement Method
open
Procurement Method Details
Open procedure
Main Procurement Category
goods
Above Threshold
Yes
How to submit
To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal
https://health-family.force.com/s/Welcome.
Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at:
Phone: 0800 9956035
E-mail: support-health@atamis.co.uk
Tender return deadline has moved from 04/11/26 to 16/11/26 due to the complexity of the procurement and the potential benefit of maximising competition and submission quality
Id
096590-2026
Lots and requirements
Entry 1
Id
1
Title
HT26-A
Description
Compounded Desferrioxamine Homecare Services
Status
active
Has Renewal
Yes
Identifiers
Entry 1
Id
HT26-A
Value
Including VAT
49,200,000
Amount
41,000,000
Currency
GBP
Award criteria
Criteria
Criterion 1
Type
price
Name
Commercial
Numbers
Entry 1
Number
40
Weight
percentageExact
Criterion 2
Type
quality
Name
Technical & Quality
Numbers
Entry 1
Number
50
Weight
percentageExact
Criterion 3
Type
quality
Name
Social Value
Numbers
Entry 1
Number
10
Weight
percentageExact
Suitability
Sme
Yes
Vcse
Yes
Contract period
Starts
1 Apr 2027, 00:00
Ends
31 Mar 2029, 23:59
Max Extent Date
31 Mar 2031, 23:59
Renewal
Description
optional 24 month extension
Entry 2
Id
HT26-B
Title
HT26-B
Description
Compounded Antimicrobial Homecare Services
Status
active
Has Renewal
Yes
Value
Including VAT
40,800,000
Amount
34,000,000
Currency
GBP
Award criteria
Criteria
Criterion 1
Type
price
Name
Commercial
Numbers
Entry 1
Number
40
Weight
percentageExact
Criterion 2
Type
quality
Name
Technical & Quality
Numbers
Entry 1
Number
50
Weight
percentageExact
Criterion 3
Type
quality
Name
Social Value
Numbers
Entry 1
Number
10
Weight
percentageExact
Suitability
Sme
Yes
Vcse
Yes
Contract period
Starts
1 Apr 2027, 00:00
Ends
31 Mar 2029, 23:59
Max Extent Date
31 Mar 2031, 23:59
Renewal
Description
optional 24 month extension
Entry 3
Id
HT26-C
Title
HT26-C
Description
Unlicensed Compounded Chemotherapy and Monoclonal Antibody Homecare Medicines Services
Status
active
Has Renewal
Yes
Value
Including VAT
86,400,000
Amount
72,000,000
Currency
GBP
Award criteria
Criteria
Criterion 1
Type
price
Name
Commercial
Numbers
Entry 1
Number
40
Weight
percentageExact
Criterion 2
Type
quality
Name
Technical & Quality
Numbers
Entry 1
Number
50
Weight
percentageExact
Criterion 3
Type
quality
Name
Social Value
Numbers
Entry 1
Number
10
Weight
percentageExact
Suitability
Sme
Yes
Vcse
Yes
Contract period
Starts
1 Apr 2027, 00:00
Ends
31 Mar 2029, 23:59
Max Extent Date
31 Mar 2031, 23:59
Renewal
Description
optional 24 month extension
Entry 4
Id
HT26-D
Title
HT26-D
Description
Other Unlicensed Compounded Homecare Medicines Services
Status
active
Has Renewal
Yes
Value
Including VAT
2,400,000
Amount
2,000,000
Currency
GBP
Award criteria
Criteria
Criterion 1
Type
price
Name
Commercial
Numbers
Entry 1
Number
40
Weight
percentageExact
Criterion 2
Type
quality
Name
Technical & Quality
Numbers
Entry 1
Number
50
Weight
percentageExact
Criterion 3
Type
quality
Name
Social Value
Numbers
Entry 1
Number
10
Weight
percentageExact
Suitability
Sme
Yes
Vcse
Yes
Contract period
Starts
1 Apr 2027, 00:00
Ends
31 Mar 2029, 23:59
Max Extent Date
31 Mar 2031, 23:59
Renewal
Description
optional 24 month extension
Entry 5
Id
HT26-E
Title
HT26-E
Description
Metabolic Disorders Homecare Medicines Services
Status
active
Has Renewal
Yes
Value
Including VAT
14,400,000
Amount
12,000,000
Currency
GBP
Award criteria
Criteria
Criterion 1
Type
price
Name
Commercial
Numbers
Entry 1
Number
40
Weight
percentageExact
Criterion 2
Type
quality
Name
Technical & Quality
Numbers
Entry 1
Number
50
Weight
percentageExact
Criterion 3
Type
quality
Name
Social Value
Numbers
Entry 1
Number
10
Weight
percentageExact
Suitability
Sme
Yes
Vcse
Yes
Contract period
Starts
1 Apr 2027, 00:00
Ends
31 Mar 2029, 23:59
Max Extent Date
31 Mar 2031, 23:59
Renewal
Description
optional 24 month extension
Entry 6
Id
HT26-F
Title
HT26-F
Description
Other Non-Compounded High Tech Homecare Medicines Services
Status
active
Has Renewal
Yes
Value
Including VAT
46,800,000
Amount
39,000,000
Currency
GBP
Award criteria
Criteria
Criterion 1
Type
price
Name
Commercial
Numbers
Entry 1
Number
40
Weight
percentageExact
Criterion 2
Type
quality
Name
Technical & Quality
Numbers
Entry 1
Number
50
Weight
percentageExact
Criterion 3
Type
quality
Name
Social Value
Numbers
Entry 1
Number
10
Weight
percentageExact
Suitability
Sme
Yes
Vcse
Yes
Contract period
Starts
1 Apr 2027, 00:00
Ends
31 Mar 2029, 23:59
Max Extent Date
31 Mar 2031, 23:59
Renewal
Description
optional 24 month extension
Items and delivery
Item 1
Id
1
Related Lot
1
Additional Classifications
Entry 1
Scheme
CPV
Id
33600000
Description
Pharmaceutical products
Entry 2
Scheme
CPV
Id
85149000
Description
Pharmacy services
Item 2
Id
HT26-B
Related Lot
HT26-B
Additional Classifications
Entry 1
Scheme
CPV
Id
33600000
Description
Pharmaceutical products
Entry 2
Scheme
CPV
Id
85149000
Description
Pharmacy services
Item 3
Id
HT26-C
Related Lot
HT26-C
Additional Classifications
Entry 1
Scheme
CPV
Id
33600000
Description
Pharmaceutical products
Entry 2
Scheme
CPV
Id
85149000
Description
Pharmacy services
Item 4
Id
HT26-D
Related Lot
HT26-D
Additional Classifications
Entry 1
Scheme
CPV
Id
33600000
Description
Pharmaceutical products
Entry 2
Scheme
CPV
Id
85149000
Description
Pharmacy services
Item 5
Id
HT26-E
Related Lot
HT26-E
Additional Classifications
Entry 1
Scheme
CPV
Id
33600000
Description
Pharmaceutical products
Entry 2
Scheme
CPV
Id
85149000
Description
Pharmacy services
Item 6
Id
HT26-F
Related Lot
HT26-F
Additional Classifications
Entry 1
Scheme
CPV
Id
33600000
Description
Pharmaceutical products
Entry 2
Scheme
CPV
Id
85149000
Description
Pharmacy services
Published documents
Entry 1
Id
L-4001
Document Type
biddingDocuments
Description
Invitation to Tender Pack for NEYPPC High Tech Homecare Medicines Services
3 published notice versions reviewed by ProcuraAxis.
3 VERSIONS
1
001447-2026Preliminary market engagement notice on Find a Tender ·
2
090710-2026Tender notice on Find a Tender ·
3
096590-2026Tender notice on Find a Tender ·
PROCURAAXIS ANALYSIS
ProcuraAxis Analysis
Our approved analysis of the opportunity appears below the official tender information.
ANALYSIS PREVIEW
Opportunity intelligence at a glance
Leeds Teaching Hospitals NHS Trust, acting through NEYPPC, is running an open procedure to establish a multi-award framework for high-tech homecare medicines services. The six lots cover compounded and non-compounded homecare medicines, including desferrioxamine, antimicrobials, chemotherapy/monoclonal antibodies and metabolic-disorder medicines.
Who this may suit
Potential fit for suppliers able to provide specialised high-tech homecare medicines and associated pharmacy services in one or more of the six service areas. Detailed supplier eligibility, quality, accreditation and submission requirements are not supplied.
Key points identified
Framework scopeProvision of high-tech homecare medicines services for member Trusts in the NEY region, with approved access for eligible non-member public entities.Evidence: “The scope of this procurement will encompass all High Tech Homecare Medicines Services required by member Trusts within the NEY region, while also allowing access for non-member Trusts.”
Lot structureSix lots: HT26-A to HT26-F covering specified compounded and non-compounded homecare medicines services.Evidence: “The expectation is that the Framework will be multi-award, structured into the following Lots” followed by Lots HT26-A to HT26-F.
Detailed supplier requirementsUnknown from supplied evidence.Evidence: No detailed selection, technical, quality, insurance or staffing requirements are provided in the supplied notice data.
96% approved-analysis confidence5 supplier criteria identified3 risks or unknowns
ProcuraAxis structures information found in published procurement records, checks the result for consistency and publishes only approved analysis. Confidence describes the completeness and consistency of the available source information; it is not a guarantee of eligibility or contract award.
Leeds Teaching Hospitals NHS Trust, acting through NEYPPC, is running an open procedure to establish a multi-award framework for high-tech homecare medicines services. The six lots cover compounded and non-compounded homecare medicines, including desferrioxamine, antimicrobials, chemotherapy/monoclonal antibodies and metabolic-disorder medicines.
Who this may suit
Potential fit for suppliers able to provide specialised high-tech homecare medicines and associated pharmacy services in one or more of the six service areas. Detailed supplier eligibility, quality, accreditation and submission requirements are not supplied.
Key deliverables
Compounded desferrioxamine homecare services
Compounded antimicrobial homecare services
Unlicensed compounded chemotherapy and monoclonal antibody homecare medicines services
Other unlicensed compounded homecare medicines services
Metabolic disorders homecare medicines services
Other non-compounded high-tech homecare medicines services
SUPPLIER REQUIREMENTS
5 criteria identified
Framework scope
98% confidence
Provision of high-tech homecare medicines services for member Trusts in the NEY region, with approved access for eligible non-member public entities.
View supporting evidence
“The scope of this procurement will encompass all High Tech Homecare Medicines Services required by member Trusts within the NEY region, while also allowing access for non-member Trusts.”
Lot structure
99% confidence
Six lots: HT26-A to HT26-F covering specified compounded and non-compounded homecare medicines services.
View supporting evidence
“The expectation is that the Framework will be multi-award, structured into the following Lots” followed by Lots HT26-A to HT26-F.
Detailed supplier requirements
98% confidence
Unknown from supplied evidence.
View supporting evidence
No detailed selection, technical, quality, insurance or staffing requirements are provided in the supplied notice data.
Supplier eligibility criteria
99% confidence
Unknown from supplied evidence.
View supporting evidence
The supplied data does not state supplier eligibility or exclusion criteria.
Framework user access
97% confidence
Member Trusts in the NEY region; non-member access may be available to publicly funded entities with prior Authority approval.
View supporting evidence
“Access for non-member Trusts will be available to any publicly funded entity, subject to prior approval from the Authority.”
“The expectation is that the Framework will be multi-award.”
Contract term and payment terms
99% confidence
Unknown from supplied evidence.
View supporting evidence
No contract start/end dates or payment terms are supplied.
Delivery
Service coverage
97% confidence
NEY region member Trusts, with potential approved use by non-member publicly funded entities.
View supporting evidence
The description specifies member Trusts within the NEY region and approved non-member access.
Buyer location
99% confidence
Leeds, United Kingdom (LS1 3EX).
View supporting evidence
Supplied buyer location is Leeds, UKE42, LS1 3EX, United Kingdom.
Delivery timetable
99% confidence
Unknown from supplied evidence.
View supporting evidence
Contract start and end dates are null.
PROCEDURE
How to respond
Procedure
99% confidence
Open procedure.
View supporting evidence
procurement_method_details: “Open procedure”.
Opportunity status
99% confidence
Open tender.
View supporting evidence
display_status is “open” and source_status is “active”.
Submission deadline
99% confidence
16 November 2026, 12:00 UTC.
View supporting evidence
submission_deadline: 2026-11-16T12:00:00Z; the same deadline is shown for every supplied lot.
Submission route
92% confidence
Invitation to Tender Pack is referenced via the Atamis portal.
View supporting evidence
Bidding document: “Invitation to Tender Pack for NEYPPC High Tech Homecare Medicines Services”, URL https://atamis-1928.my.site.com/s/Welcome.
RISKS AND UNKNOWNS
Points requiring attention
Lot identifier inconsistency
99% confidence
The first lot is described and titled as HT26-A, but its supplied lot_id is “1”; the other lots use HT26-B to HT26-F as identifiers.
View supporting evidence
Lot 1 has lot_id “1” and title “HT26-A”; subsequent records use lot_id and title HT26-B through HT26-F.
Detailed tender conditions unavailable
99% confidence
Supplier selection requirements, certifications, service specifications, pricing schedules and contract terms are not included in the supplied evidence.
View supporting evidence
Only summary notice data and a link to an Invitation to Tender Pack are supplied.
Framework award expectation
94% confidence
The notice states that multi-award is an expectation, rather than a confirmed final award structure.
View supporting evidence
“The expectation is that the Framework will be multi-award.”
ProcuraAxis analysis supplements, but does not replace, the original notice and tender documents. Always verify eligibility, deadlines and commercial terms with the issuing authority.
Continue in your ProcuraAxis workspaceFree account · Full approved analysis